Sanofi’s AGM last week saw surprise opposition to sacked CEO Chris Viehbacher’s €4.4m ($4.91m) exit deal, and to new Chief Olivier Brandicourt’s starting bonus.
Kaare Schultz, Novo Nordisk Chief Operating Officer and planned successor as Chief Executive, resigned unexpectedly today. Plus FDA's ex-top scientist heads up US Pharmacopoeia.